Skip to main content

Part of the book series: Specialty Topics in Pediatric Neuropsychology ((STPN))

Abstract

Endocrine complications, which are mostly complications of cancer treatments, can affect between 20 % and 50 % of childhood cancer survivors. They are among the most frequently observed therapy related late effects. Affected systems include the hypothalamus and pituitary, the thyroid, the gonads as well as various systems regulating bone health, body composition and glucose metabolism. Early diagnosis and treatment of these complications can improve the health prognosis of affected individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Diller, L., Chow, E. J., Gurney, G. J., Hudson, M. M., Kadin-Lottick, N. S., Kawashima, T. I., et al. (2009). Chronic disease in the childhood cancer survivor study cohort: A review of published findings. Journal of Clinical Oncology, 27, 2339–2355.

    PubMed Central  PubMed  Google Scholar 

  2. Gurney, J. G., Kadan-Lottick, N. S., Packer, R. J., Neglia, J. P., Sklar, C. A., Punyko, J. A., et al. (2003). Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood cancer survivor study. Cancer, 97, 663–673.

    PubMed  Google Scholar 

  3. Hows, J. M., Passweg, J. R., Tichelli, A., Locasciulli, A., Szydlo, R., Bacigalupo, A., et al. (2006). Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplantation, 38, 799–805.

    PubMed  Google Scholar 

  4. Sklar, C. A., & Constine, L. S. (1995). Chronic neuro-endocrinological sequelae of radiation therapy. International Journal of Radiation Oncology, Biology, and Physics, 31, 1113–1120.

    Google Scholar 

  5. Laughton, S. J., Merchant, T. E., Sklar, C. A., Kun, L. E., Fouladi, M., Broniscer, A., et al. (2008). Endocrine outcomes for children with embryonal brain tumors after risk adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem cell rescue on the SJMB-96 trial. Journal of Clinical Oncology, 26, 1112–1118.

    PubMed  Google Scholar 

  6. Clayton, P. E., & Shalet, S. M. (1991). Dose dependency of time of onset of radiation-induced growth hormone deficiency. Journal of Pediatrics, 118, 226–228.

    PubMed  Google Scholar 

  7. Brennan, B. M., Rahim, A., Mackie, E. M., Eden, O. B., & Shalet, S. M. (1998). Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clinical Endocrinology, 48, 777–783.

    PubMed  Google Scholar 

  8. Rose, S. R., Schreiber, R. E., Kearney, N. S., Lustig, R. H., Danish, R. K., Burghen, G. A., et al. (2004). Hypothalamic dysfunction after chemotherapy. Journal of Pediatric Endocrinology and Metabolism, 17, 55–66.

    PubMed  Google Scholar 

  9. Bakker, B., Oostdijk, W., Bresters, D., Walenkamp, M. J., Vossen, J. M., & Wit, J. M. (2004). Disturbances of growth and endocrine function after busulfan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplantation, 33, 1049–1056.

    PubMed  Google Scholar 

  10. Gurney, J. G., Ness, K. K., Sibley, S. D., O’Leary, M., Dengel, D. R., Lee, J. M., et al. (2006). Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer, 107, 1303–1312.

    PubMed  Google Scholar 

  11. van den Heijkant, S., Hoorweg-Nijman, G., Huisman, J., Drent, M., van der Pal, H., Kaspers, G., et al. (2011). Effects of growth hormone therapy on bone mass, metabolic balance and well-being in young adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 33, 231–238.

    Google Scholar 

  12. Reiter, E. O., & Rosenfeld, R. G. (2003). Normal and abnormal growth. In P. R. Larsen, H. M. Kronenberg, & S. Melmed (Eds.), Williams textbook of endocrinology (pp. 1003–1014). Philadelphia: WB Saunders.

    Google Scholar 

  13. Shalet, S. M., Gibson, B., Swindell, R., & Pearson, D. (1987). Effects of spinal irradiation on growth. Archives of Disease in Childhood, 62, 461–464.

    PubMed Central  PubMed  Google Scholar 

  14. Brauner, R., Fontoura, M., Zucker, J. M., Devergie, A., Souberbielle, J. C., Prevot-Saucet, C., et al. (1993). Growth and growth hormone secretion after bone marrow transplantation. Archives of Disease in Childhood, 64, 458–463.

    Google Scholar 

  15. Thomas, B. C., Stanhope, R., Plowman, P. N., & Leiper, A. D. (1993). Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. European Journal of Pediatrics, 152, 888–892.

    PubMed  Google Scholar 

  16. Clayton, P. E., & Shalet, S. M. (1991). The evolution of spinal growth after irradiation. Clinical Oncology, 3, 220–222.

    PubMed  Google Scholar 

  17. Ho, K. K. (2007). Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society and Endocrine Society of Australia. European Journal of Endocrinology, 157, 695–700.

    PubMed  Google Scholar 

  18. Growth Hormone Research Society. (2000). Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society. Journal of Clinical Endocrinology and Metabolism, 85, 3990–3993.

    Google Scholar 

  19. Sklar, C., Sarafoglou, K., & Whittam, E. (1993). Efficacy of insulin-like growth factor binding protein-3 (IGFBP-3) in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinologica, 129, 511–515.

    PubMed  Google Scholar 

  20. Weinzimer, S. A., Homan, S. A., Ferry, R. J., & Moshang, T. (1999). Serum IGF-1 and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumors. Clinical Endocrinology, 51, 339–345.

    PubMed  Google Scholar 

  21. Greulich, W., & Pyle, S. (1959). Radiographic atlas of skeletal development of the hand and wrist (2nd ed.). Stanford: Stanford University Press.

    Google Scholar 

  22. Adan, L., Sainte-Rose, C., Souberbielle, J. C., Zucker, J. M., Kalifa, C., & Brauner, R. (2000). Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation. Medical and Pediatric Oncology, 34, 14–19.

    PubMed  Google Scholar 

  23. Gleeson, H. K., Stoeter, R., Ogilvy-Stuart, A. L., Gattamaneni, H. R., Brennan, B. M., & Shalet, S. M. (2003). Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumours receiving GH replacement. Journal of Clinical Endocrinology and Metabolism, 88, 3682–3689.

    PubMed  Google Scholar 

  24. Brownstein, C. M., Mertens, A. C., Mitby, P. A., Stovall, M., Qin, J., Heller, G., et al. (2004). Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism, 89, 4422–4427.

    PubMed  Google Scholar 

  25. Swerdlow, A. J., Reddingius, R. E., Higgins, C. D., Spoudeas, H. A., Phipps, K., Qiao, Z., et al. (2000). Growth hormone treatment of children with brain tumours and risk of tumour recurrence. Journal of Clinical Endocrinology and Metabolism, 85, 4444–4449.

    PubMed  Google Scholar 

  26. Packer, R. J., Boyett, J. M., Janns, A. J., Stavrou, T., Kun, L., Wisoff, J., et al. (2001). Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control. Journal of Clinical Oncology, 19, 480–487.

    PubMed  Google Scholar 

  27. Sklar, C. A., Mertens, A. C., Mitby, P., Occhiogrosso, G., Qin, J., Heller, G., et al. (2002). Risk of disease recurrence and second neoplasm in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism, 87, 3136–3141.

    PubMed  Google Scholar 

  28. Ergun-Longmire, B., Mertens, A. C., Mitby, P., Qin, J., Heller, G., Shi, W., et al. (2006). Growth hormone treatment and risk of second neoplasm in the childhood cancer survivor. Journal of Clinical Endocrinology and Metabolism, 91, 3494–3498.

    PubMed  Google Scholar 

  29. Blethen, S. L., & Rundle, A. C. (1996). Slipped capital femoral epiphyses in children treated with growth hormone. A summary of the natural cooperative growth experience. Hormone Research, 46, 113–116.

    PubMed  Google Scholar 

  30. Link, K., Moëll, C., Garwicz, S., Cavallin-Ståhl, E., Björk, J., Thilén, U., et al. (2004). Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. Journal of Clinical Endocrinology and Metabolism, 89, 5003–5012.

    PubMed  Google Scholar 

  31. Murray, R. D., Darzy, K. H., Gleeson, H. K., & Shalet, S. M. (2002). GH deficient survivors of childhood cancer: GH replacement during adult life. Journal of Clinical Endocrinology and Metabolism, 87, 129–135.

    PubMed  Google Scholar 

  32. Mukherjee, A., Tolhurst-Cleaver, S., Ryder, W. D., Smethurst, L., & Shalet, S. M. (2005). The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. Journal of Clinical Endocrinology and Metabolism, 90, 1542–1549.

    PubMed  Google Scholar 

  33. Follin, C., Thilén, U., Ahrén, B., & Erfurth, E. M. (2006). Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. Journal of Clinical Endocrinology and Metabolism, 91, 1872–1875.

    PubMed  Google Scholar 

  34. Sigurjonssdottir, T., & Hayes, A. (1968). Precocious puberty: A report of 96 cases. American Journal of Diseases of Children, 1115, 309–321.

    Google Scholar 

  35. Brauner, R., Czernichow, P., & Rappaport, R. (1984). Precocious puberty after hypothalamic and pituitary irradiation in young children. New England Journal of Medicine, 311, 920.

    PubMed  Google Scholar 

  36. Constine, L. S., Woolf, P. D., Cann, D., Mick, G., McCormick, K., Raubertas, R. F., et al. (1993). Hypothalamic pituitary dysfunction after radiation for brain tumors. New England Journal of Medicine, 328, 87–94.

    PubMed  Google Scholar 

  37. Oberfield, S. E., Soranno, D., Nirenberg, A., Heller, G., Allen, J. C., David, R., et al. (1996). Age at the onset of puberty following high-dose central nervous system radiation therapy. Archives of Pediatrics and Adolescent Medicine, 150, 589–592.

    PubMed  Google Scholar 

  38. Chow, E. J., Friedman, D. L., Yasui, Y., Whitton, J. A., Stovall, M., Robison, L. L., et al. (2008). Timing of menarche among survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Pediatric Blood & Cancer, 50, 854–858.

    Google Scholar 

  39. Armstrong, G. T., Whitton, J. A., Gajjar, A., Kun, L. E., Chow, E. J., Stovall, M., et al. (2009). Abnormal timing of menarche in survivors of central nervous system tumors. A report from the childhood cancer survivor study. Cancer, 115, 2562–2570.

    PubMed Central  PubMed  Google Scholar 

  40. Lam, K. S. L., Tse, V. K. C., Wang, C., Yeung, R. T., & Ho, J. H. (1991). Effects of irradiation on hypothalamic pituitary function: A 5-year longitudinal study in patients with nasopharyngeal carcinoma. Quarterly Journal of Medicine, 78, 165–176.

    PubMed  Google Scholar 

  41. Ogilvy-Stuart, A. L., & Shalet, S. M. (1995). Growth and puberty after growth hormone treatment after irradiation for brain tumours. Archives of Disease in Childhood, 73, 141–146.

    PubMed Central  PubMed  Google Scholar 

  42. Relander, T., Gavallin-Stahl, E., Garwicz, S., Olsson, A. M., & Willen, M. (2000). Gonadal and sexual function in men treated for childhood cancer. Medical and Pediatric Oncology, 35, 52–63.

    PubMed  Google Scholar 

  43. Byrne, J., Fears, T. R., Mills, J. L., Zeltzer, L. K., Sklar, C., Meadows, A. T., et al. (2004). Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatric Blood & Cancer, 42, 364–372.

    Google Scholar 

  44. Green, D. M., Kawashima, T., Stovall, M., Leisenring, W., Sklar, C. A., Mertens, A. C., et al. (2009). Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 27, 2677–2685.

    PubMed Central  PubMed  Google Scholar 

  45. Bath, L. E., Anderson, R. A., Critchley, H. O. D., Kelnar, C. J., & Wallace, W. H. (2001). Hypothalamic pituitary- ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Human Reproduction, 16, 1838–1844.

    PubMed  Google Scholar 

  46. Green, D. M., Nolan, V. G., Kawashima, T., Stovall, M., Donaldson, S. S., Srivastava, D., et al. (2011). Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: A report from the childhood cancer survivor study. Fertility and Sterility, 95, 1922–1927.

    PubMed Central  PubMed  Google Scholar 

  47. Rose, S. R., Danish, R. K., Kearney, N. S., Schreiber, R. E., Lustig, R. H., Burghen, G. A., et al. (2005). ACTH deficiency in childhood cancer survivors. Pediatric Blood & Cancer, 45, 808–813.

    Google Scholar 

  48. Patterson, B. C., Truxillo, L., Wasilewski-Masker, K., Mertens, A. C., & Meacham, L. R. (2009). Adrenal function testing in pediatric cancer survivors. Pediatric Blood & Cancer, 53, 1302–1307.

    Google Scholar 

  49. Chrousos, G. P., Kino, T., & Charmandari, E. (2009). Evaluation of the hypothalamic-pituitary – adrenal axis function in childhood and adolescence. Neuroimmunomodulation, 16, 272–283.

    PubMed Central  PubMed  Google Scholar 

  50. Rose, S. R., Lustig, R. H., Pitukcheewanont, P., Broome, D. C., Burghen, G. A., Li, H., et al. (1999). Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. Journal of Clinical Endocrinology and Metabolism, 84, 4472–4479.

    PubMed  Google Scholar 

  51. Schmiegelow, M., Feldt-Rasmussen, U., Rasmussen, A. K., Poulsen, H. S., & Muller, J. (2003). A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. Journal of Clinical Endocrinology and Metabolism, 88, 136–140.

    PubMed  Google Scholar 

  52. Brabant, G., Toogood, A. A., Shalet, S. M., Frobisher, C., Lancashire, E. R., Reulen, R. C., et al. (2011). Hypothyroidism following childhood cancer therapy-an under diagnosed complication. International Journal of Cancer. doi:10.1002/ijc.26086.

    Google Scholar 

  53. Chin, D., Sklar, C., Donahue, B., Uli, N., Geneiser, N., Allen, J., et al. (1997). Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/ primitive neurectodermal tumors: A comparison of hyperfractionated versus conventional radiotherapy. Cancer, 80, 798–804.

    PubMed  Google Scholar 

  54. Sklar, C., Whitton, J., Mertens, A., Stovall, M., Green, D., Marina, N., et al. (2000). Abnormalities of the thyroid in survivors of Hodgkin’s disease: Data from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism, 85, 3227–3232.

    PubMed  Google Scholar 

  55. Van Santen, H. M., Vulsma, T., Dijkgraaf, M. G., Blumer, R. M., Heinen, R., Jaspers, M. W., et al. (2003). No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. Journal of Clinical Endocrinology and Metabolism, 88, 3657–3663.

    PubMed  Google Scholar 

  56. Chow, E. J., Friedman, D. L., Stovall, M., Yasui, Y., Whitton, J. A., Robison, L. L., et al. (2009). Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: A report from the childhood cancer survivors study. Pediatric Blood & Cancer, 53, 432–437.

    Google Scholar 

  57. Picco, P., Garaventa, A., Claudiani, F., Gattorno, M., De Bernardi, B., & Borrone, C. (1995). Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma. Cancer, 76, 1662–1664.

    PubMed  Google Scholar 

  58. Laverdiére, C., Cheung N-K, V., Kushner, B. H., Kramer, K., Modak, S., La Quaglia, M. P., et al. (2005). Long-term complications in survivors of advanced stage neuroblastoma. Pediatric Blood & Cancer, 45, 324–332.

    Google Scholar 

  59. Metzger, M. L., Howard, S. C., Hudson, M. M., Gow, K. W., Li, C. S., Krasin, M. J., et al. (2006). Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatric Blood & Cancer, 46, 314–319.

    Google Scholar 

  60. Sklar, C., Boulad, F., Small, T., & Kernan, N. (2001). Endocrine complications of pediatric stem cell transplantation. Frontiers in Bioscience, 1, G12–G22.

    Google Scholar 

  61. Au, W. Y., Ak, L., Kung, A. W., Liang, R., Hawkins, B. R., & Kwong, Y. L. (2005). Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 35, 383–388.

    PubMed  Google Scholar 

  62. Sigurdson, A. J., Ronckers, C. M., Mertens, A. C., Stovall, M., Smith, S. A., Liu, Y., et al. (2005). Primary thyroid cancer after a first tumour in childhood (the childhood cancer survivor study): A nested case-control study. Lancet, 365, 2014–2023.

    PubMed  Google Scholar 

  63. Bhatti, P., Veiga, L. H., Ronckers, C. M., Sigurdson, A. J., Stovall, M., Smith, S. A., et al. (2010). Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An update from the childhood cancer survivor study. Radiation Research, 174, 741–752.

    PubMed Central  PubMed  Google Scholar 

  64. Taylor, A. J., Croft, A. P., Palace, A. M., Winter, D. L., Reulen, R. C., Stiller, C. A., et al. (2009). Risk of thyroid cancer in survivors of childhood cancer: Results from the British childhood cancer survivor study. International Journal of Cancer, 125, 2400–2405.

    Google Scholar 

  65. Acharya, S., Sarafoglou, K., LaQuaglia, M., Lindsley, S., Gerald, W., Wollner, N., et al. (2003). Thyroid neoplasms after therapeutic radiation of malignancies during childhood or adolescence. Cancer, 97, 2397–2403.

    PubMed  Google Scholar 

  66. Bounacer, A., Wicker, R., Caillou, B., Cailleux, A. F., Sarasin, A., Schlumberger, M., et al. (1997). High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene, 15, 1263–1276.

    PubMed  Google Scholar 

  67. Elisei, R., Romei, C., Vorontsova, T., Cosci, B., Veremeychik, V., Kushinskaya, E., et al. (2001). RET/PTC rearrangements in thyroid nodules: Studies in irradiated and non irradiated malignant and benign thyroid lesions in children and adults. Journal of Clinical Endocrinology and Metabolism, 86, 3211–3216.

    PubMed  Google Scholar 

  68. Brignardello, E., Corrias, A., Isolato, G., Palestini, N., Cordero di Montezemolo, L., Fagioli, F., et al. (2008). Ultrasound screening for thyroid carcinoma in childhood cancer survivors: A case series. Journal of Clinical Endocrinology and Metabolism, 93, 4840–4843.

    PubMed  Google Scholar 

  69. Griffin, J. E., & Wilson, J. D. (1992). Disorders of the testes and the male reproductive tract. In J. D. Wilson & D. W. Foster (Eds.), Williams textbook of endocrinology (Vol. 8, pp. 799–852). Philadelphia: WB Saunders.

    Google Scholar 

  70. Blatt, J., Poplack, D. G., & Sherins, R. J. (1981). Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. New England Journal of Medicine, 304, 1121–1124.

    PubMed  Google Scholar 

  71. Sklar, C. (1999). Reproductive physiology and treatment-related loss of sex-hormone production. Medical and Pediatric Oncology, 33, 2–8.

    PubMed  Google Scholar 

  72. Bramswig, J. H., Heimes, U., Heiermann, E., Schlegel, W., Nieschlag, E., & Schellong, G. (1990). The effect of different cumulative doses of chemotherapy on testicular function. Cancer, 65, 1298–1302.

    PubMed  Google Scholar 

  73. Siimes, M. A., Rautonen, J., Makipernaa, A., & Sipila, I. (1995). Testicular function in adult males surviving childhood malignancy. Pediatric Hematology and Oncology, 12, 231–241.

    PubMed  Google Scholar 

  74. Mackie, E. J., Radford, M., & Shalet, S. M. (1996). Gonadal function following chemotherapy for childhood Hodgkin’s disease. Medical and Pediatric Oncology, 27, 74–78.

    PubMed  Google Scholar 

  75. Heikens, J., Behrendt, H., Adriaanse, R., & Berghout, A. (1996). Irreversible gonadal damage in male survivors of pediatric Hodgkin’s disease. Cancer, 78, 2020–2024.

    PubMed  Google Scholar 

  76. Papadakis, V., Vlachopapadopoulou, E., Van Syckle, K., Ganshaw, L., Kalmanti, M., Tan, C., et al. (1999). Gonadal function in young patients successfully treated for Hodgkin’s disease. Medical and Pediatric Oncology, 32, 366–372.

    PubMed  Google Scholar 

  77. Kenney, L. B., Laufer, M. R., Grant, F. D., Grier, H., & Diller, L. (2001). High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer, 91, 613–621.

    PubMed  Google Scholar 

  78. Romerius, P., Ståhl, O., Moëll, C., Relander, T., Cavallin-Ståhl, E., Wiebe, T., et al. (2009). Hypogonadism risk in men treated for childhood cancer. Journal of Clinical Endocrinology and Metabolism, 94, 4180–4186.

    PubMed  Google Scholar 

  79. Afify, A., Shaw, P. J., Clavano-Harding, A., & Cowell, C. T. (2000). Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplantation, 25b, 1087–1092.

    Google Scholar 

  80. Sanders, J. E. (2004). Endocrine complications of high-dose therapy with stem cell transplantation. Pediatric Transplantation, 8(Suppl 5), 39–50.

    PubMed  Google Scholar 

  81. Leiper, A. D., Grant, D. B., & Chessels, J. M. (1986). Gonadal function after testicular radiation for acute lymphoblastic leukemia. Archives of Disease in Childhood, 61, 53–56.

    PubMed Central  PubMed  Google Scholar 

  82. Shalet, S. M., Tsatsoulis, A., Whitehead, E., & Read, G. (1989). Vulnerability of the human Leydig cell to radiation damage is dependent upon age. Journal of Endocrinology, 120, 161–165.

    PubMed  Google Scholar 

  83. Sarafoglou, K., Boulad, F., Gillio, A., & Sklar, C. (1997). Gonadal function after bone marrow transplantation for acute leukemia during childhood. Journal of Pediatrics, 130, 210–216.

    PubMed  Google Scholar 

  84. Izard, M. A. (1995). Leydig cell function and radiation: A review of the literature. Radiotherapy and Oncology, 34, 1–8.

    PubMed  Google Scholar 

  85. Lewis, K., & Lee, P. A. (2009). Endocrinology of male puberty. Current Opinion in Endocrinology, Diabetes, and Obesity, 16, 5–9.

    PubMed  Google Scholar 

  86. Rendtorff, R., Beyer, M., Muller, A., Dittrich, R., Hohmann, C., Keil, T., et al. (2011). Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors. Andrologia. doi:10.1111/j.1439-0272.2011.01167.x.

    PubMed  Google Scholar 

  87. López Andreu, J. A. L., Fernandez, P. J., Ferrís i Tortajada, J. F., Navarro, I., Rodriguez-Ineba, A., Antonio, P., et al. (2000). Persistent altered spermatogenesis in long-term childhood cancer survivors. Pediatric Hematology and Oncology, 17, 21–30.

    PubMed  Google Scholar 

  88. van den Berg, H., Furstner, F., van den Bos, C., & Begrendt, H. (2004). Decreasing the number of MOPP courses reduces gonadal damage in childhood Hodgkin’s disease. Pediatric Blood & Cancer, 42, 210–215.

    Google Scholar 

  89. Grigg, A. P., McLachlan, R., Zajac, J., & Szer, J. (2000). Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplantation, 26, 1089–1095.

    PubMed  Google Scholar 

  90. Anserini, P., Chiodi, S., Spinelli, S., Costa, M., Conte, N., Copello, F., et al. (2002). Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplantation, 30, 447–451.

    PubMed  Google Scholar 

  91. Meistrich, M. L., Vassillopoulou-Sellin, R., & Lipshultz, L. I. (1997). Gonadal dysfunction. In V. T. DeVita Jr., S. Hellman, & S. A. Rosenberg (Eds.), Cancer: Principles and practice of oncology (Vol. 5, pp. 2758–2773). Philadelphia: Lippincott-Raven.

    Google Scholar 

  92. Sanders, J. E., Hawley, J., Levy, W., Gooley, T., Buckner, C. D., Deeg, H. J., et al. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87, 3045–3052.

    PubMed  Google Scholar 

  93. Carr, B. R. (1992). Disorders of the ovary and the reproductive tract. In J. D. Wilson & D. W. Foster (Eds.), Williams textbook of endocrinology (Vol. 8, pp. 733–798). Philadelphia: WB Saunders.

    Google Scholar 

  94. Chemaitilly, W., Mertens, A. C., Mitby, P., Whitton, J., Stovall, M., Yasui, Y., et al. (2006). Acute ovarian failure in the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism, 91, 1723–1728.

    PubMed  Google Scholar 

  95. Sklar, C. A., Mertens, A. C., Mitby, P., Whitton, J., Stovall, M., Kasper, C., et al. (2006). Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. Journal of the National Cancer Institute, 98, 890–896.

    PubMed  Google Scholar 

  96. Rivkees, S. A., & Crawford, J. D. (1988). The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA, 259, 2123–2125.

    PubMed  Google Scholar 

  97. Wallace, W. H. B., Shalet, S. M., Crown, E. C., Morris-Jones, P. H., & Gattamaneni, H. R. (1989). Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis. Clinical Oncology, 1, 75–79.

    PubMed  Google Scholar 

  98. Michel, G., Socie, G., Gebhard, F., Bernaudin, F., Thuret, I., Vannier, J. P., et al. (1997). Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation—A report from the Société Française de Greffe de Moelle. Journal of Clinical Oncology, 15, 2238–2246.

    PubMed  Google Scholar 

  99. Horning, S. J., Hoppe, R. T., Kaplan, H. S., & Rosenberg, S. A. (1981). Female reproductive potential after treatment for Hodgkin’s disease. New England Journal of Medicine, 304, 1377–1382.

    PubMed  Google Scholar 

  100. Hudson, M. M., Greenwald, C., Thompson, E., Wilimas, J., Marina, N., Fairclough, D., et al. (1993). Efficacy and toxicity of multiagent chemotherapy and low-dose involved field radiotherapy in children and adolescents with Hodgkin’s disease. Journal of Clinical Oncology, 11, 100–108.

    PubMed  Google Scholar 

  101. Byrne, J., Fears, T. R., Gail, M. H., Pee, D., Connelli, R. R., Austin, D. F., et al. (1992). Early menopause in long-term survivors of cancer during adolescence. American Journal of Obstetrics and Gynecology, 166, 788–793.

    PubMed  Google Scholar 

  102. Nasir, J., Walton, C., Lindow, S. W., & Masson, E. A. (1997). Spontaneous recovery of chemotherapy-induced primary ovarian failure: Implication for management. Clinical Endocrinology, 46, 217–219.

    PubMed  Google Scholar 

  103. Green, D. M., Whitton, J. A., Stovall, M., Mertens, A. C., Donaldson, S. S., Ruymann, F. B., et al. (2002). Pregnancy outcome of female survivors of childhood cancer: A report from the childhood cancer survivor study. American Journal of Obstetrics and Gynecology, 187, 1070–1080.

    PubMed  Google Scholar 

  104. Wallace, W. H., Shalet, S. M., Crowne, E. C., Morris-Jones, P. H., Gattamaneni, H. R., & Price, D. A. (1989). Gonadal dysfunction due to cis-platinum. Medical and Pediatric Oncology, 17, 409–413.

    PubMed  Google Scholar 

  105. Damewood, M. D., & Grochow, L. B. (1986). Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertility and Sterility, 45, 443–459.

    PubMed  Google Scholar 

  106. Thibaud, E., Rodriguez-Macias, K., Trivin, C., Esperou, H., Michon, J., & Brauner, R. (1998). Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplantation, 21, 287–290.

    PubMed  Google Scholar 

  107. Hamre, M. R., Robison, L. L., Nesbit, M. E., Sather, H. N., Meadows, A. T., Ortega, J. A., et al. (1987). Effects of radiation on ovarian function in long term survivors of childhood acute lymphoblastic leukemia: A report from the children cancer study group. Journal of Clinical Oncology, 5, 1759–1765.

    PubMed  Google Scholar 

  108. Clayton, P. E., Shalet, S. M., Price, D. A., & Jones, P. H. (1989). Ovarian function following chemotherapy for childhood brain tumours. Medical and Pediatric Oncology, 17, 92–96.

    PubMed  Google Scholar 

  109. Thibaud, E., Ramirez, M., Brauner, R., Flamant, F., Zucker, J. M., Fekete, C., et al. (1992). Preservation of ovarian function by ovarian transposition performed before pelvic irradiation in childhood. Journal of Pediatrics, 12, 880–884.

    Google Scholar 

  110. Signorello, L. B., Mulvihill, J. J., Green, D. M., Munro, H. M., Stovall, M., Weathers, R. E., et al. (2010). Still birth and neonatal death in relation to radiation exposure before conception: A retrospective cohort study. Lancet, 376, 624–630.

    PubMed Central  PubMed  Google Scholar 

  111. Matsumoto, M., Shinohara, O., Ishiguro, H., Shimizu, T., Hattori, K., Ichikawa, M., et al. (1999). Ovarian function after bone marrow transplantation performed before menarche. Archives of Disease in Childhood, 80, 452–454.

    PubMed Central  PubMed  Google Scholar 

  112. Sanders, J. E., Buckner, C. D., Amos, D., Levy, W., Appelbaum, F. R., Doney, K., et al. (1988). Ovarian function following marrow transplantation for aplastic anemia or leukemia. Journal of Clinical Oncology, 6, 813–818.

    PubMed  Google Scholar 

  113. Holm, K., Nysom, K., Brocks, V., Hertz, H., Jacobsen, N., & Muller, J. (1999). Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplantation, 23, 259–263.

    PubMed  Google Scholar 

  114. Bath, L. E., Critchley, H. O. D., Chambers, S. E., Anderson, R. A., Kelnar, C. J., & Wallace, W. H. (1999). Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: Response to sex steroid replacement. British Journal of Obstetrics and Gynaecology, 106, 1265–1272.

    PubMed  Google Scholar 

  115. Larsen, E. C., Schmiegelow, K., Rechnitzer, C., Loft, A., Muller, J., & Andersen, A. N. (2004). Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstetricia et Gynecologica Scandinavica, 83, 96–102.

    PubMed  Google Scholar 

  116. Aisenberg, J., Hsieh, K., Kalaitzoglou, G., Whittam, E., Heller, G., Schneider, R., et al. (1998). Bone mineral density (BMD) in long-term survivors of childhood cancer. Journal of Pediatric Hematology/Oncology, 20, 241–245.

    PubMed  Google Scholar 

  117. Visser, J. A., de Jong, F. H., Laven, J. S., & Themmen, A. P. (2006). Anti-Müllerian hormone: A new marker for ovarian function. Reproduction, 131, 1–9.

    PubMed  Google Scholar 

  118. Lie Fong, S., Laven, J. S., Hakvoort-Cammel, F. G., Schipper, I., Visser, J. A., Themmen, A. P., et al. (2009). Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Human Reproduction, 24, 982–990.

    PubMed  Google Scholar 

  119. Sala, A., & Barr, R. D. (2007). Osteopenia and cancer in children and adolescents: The fragility of success. Cancer, 109, 1420–1431.

    PubMed  Google Scholar 

  120. Wasilewski-Masker, K., Kaste, S. C., Hudson, M. M., Esiashvili, N., Mattano, L. A., & Meacham, L. R. (2008). Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics, 121, e705–e713.

    PubMed  Google Scholar 

  121. Crofton, P. M., Ahmed, S. F., Wade, J. C., Stephen, R., Elmlinger, M. W., Ranke, M. B., et al. (1998). Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. Journal of Clinical Endocrinology and Metabolism, 83, 3121–3129.

    PubMed  Google Scholar 

  122. De Boer, H., Blok, G. J., Van Lingen, A., Teule, G. J., Lips, P., & van der Veen, E. A. (1994). Consequences of childhood onset growth hormone deficiency for adult bone mass. Journal of Bone and Mineral Research, 9, 1319–1326.

    PubMed  Google Scholar 

  123. Stanislavejic, S., & Babcock, A. L. (1997). Fractures in children treated with methotrexate for leukemia. Clinical Orthopaedics and Related Research, 125, 139–144.

    Google Scholar 

  124. Brennan, B. M. D., Rahim, A., Adams, J. A., Eden, O. B., & Shalet, S. M. (1999). Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. British Journal of Cancer, 79, 1859–1863.

    PubMed Central  PubMed  Google Scholar 

  125. Nysom, K., Holm, K., Michaelsen, K. F., Hertz, H., Jacobsen, N., Müller, J., et al. (2000). Bone mass after allogeneic bone marrow transplantation for childhood leukaemia or lymphoma. Bone Marrow Transplantation, 25, 191–196.

    PubMed  Google Scholar 

  126. Halton, J. M., Atkinson, S. A., Fraher, L., Webber, C., Gill, G. J., Dawson, S., et al. (1996). Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. Journal of Bone and Mineral Research, 11, 1774–1783.

    PubMed  Google Scholar 

  127. Thomas, I. H., Donohue, J. E., Ness, K. K., Dengel, D. R., Baker, K. S., & Gurney, J. G. (2008). Bone mineral density in young adult survivors of acute lymphoblastic leukemia. Cancer, 113, 3248–3256.

    PubMed Central  PubMed  Google Scholar 

  128. Jones, T. S., Kaste, S. C., Liu, W., Cheng, C., Yang, W., Tantisira, K. G., et al. (2008). CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. Journal of Clinical Oncology, 26, 3031–3037.

    PubMed  Google Scholar 

  129. Gafni, R. I., & Baron, J. (2004). Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). Journal of Pediatrics, 144, 53–57.

    Google Scholar 

  130. Ruble, K., Hayat, M. J., Stewart, K. J., & Chen, A. R. (2010). Bone mineral density after bone marrow transplantation in childhood: Measurements and associations. Biology of Blood and Marrow Transplantation, 16, 1451–1457.

    PubMed Central  PubMed  Google Scholar 

  131. Sklar, C. A., Mertens, A. C., Walter, A., Mitchell, D., Nesbit, M. E., O’Leary, M., et al. (2000). Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: Role of cranial irradiation. Medical and Pediatric Oncology, 35, 91–95.

    PubMed  Google Scholar 

  132. Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Yasui, Y., Fears, T., Stovall, M., et al. (2003). Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 21, 1359–1365.

    PubMed  Google Scholar 

  133. Garmey, E. G., Liu, Q., Sklar, C. A., Meacham, L. R., Mertens, A. C., Stovall, M. A., et al. (2008). Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 26, 4639–4645.

    PubMed Central  PubMed  Google Scholar 

  134. Ross, J. A., Oeffinger, K. C., Davies, S. M., Mertens, A. C., Langer, E. K., Kiffmeyer, W. R., et al. (2004). Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 22, 3558–3562.

    PubMed  Google Scholar 

  135. Armenian, S. H., & Bhatia, S. (2009). Chronic health conditions in childhood cancer survivors: Is it all treatment-related–or do genetics play a role? Journal of General Internal Medicine, 24(Suppl 2), S395–S400.

    PubMed  Google Scholar 

  136. Reilly, J. J., Vetham, J. C., Ralston, J. M., Donaldson, M., & Gibson, B. (1998). Reduced energy expenditure in pre-obese children treated for acute lymphoblastic leukemia. Pediatric Research, 44, 557–562.

    PubMed  Google Scholar 

  137. Talvensaari, K. K., Lanning, M., Tapanainen, P., & Knip, M. (1996). Long term survivors of childhood cancer survivors have an increased risk of manifesting the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 81, 3051–3055.

    PubMed  Google Scholar 

  138. Reilly, J. J., Kelly, A., Ness, P., Dorosty, A. R., Wallace, W. H., Gibson, B. E., et al. (2001). Premature adiposity rebound in children treated for acute lymphoblastic leukaemia. Journal of Clinical Endocrinology and Metabolism, 86, 3742–3745.

    PubMed  Google Scholar 

  139. Lustig, R. H., Post, S. R., Srivannaboon, K., Rose, S. R., Danish, R. K., Burghen, G. A., et al. (2003). Risk factors for the development of obesity in children surviving brain tumors. Journal of Clinical Endocrinology and Metabolism, 88, 611–616.

    PubMed  Google Scholar 

  140. Lustig, R. H., Hinds, P. S., Ringwald-Smith, K., Christensen, R. K., Kaste, S. C., Schreiber, R. E., et al. (2003). Octreotide therapy of pediatric hypothalamic obesity: A doubleblind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 88, 2586–2592.

    PubMed  Google Scholar 

  141. Mason, P. W., Krawiecki, N., & Meacham, L. R. (2002). The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Archives of Pediatrics and Adolescent Medicine, 156, 887–892.

    PubMed  Google Scholar 

  142. Meacham, L. R., Sklar, C. A., Li, S., Liu, Q., Gimpel, N., Yasui, Y., et al. (2009). Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report from the childhood cancer survivor study. Archives of Internal Medicine, 169, 1381–1388.

    PubMed Central  PubMed  Google Scholar 

  143. Lorini, R., Cortona, L., Scaramuzza, A., De Stefano, P., Locatelli, F., Bonetti, F., et al. (1995). Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplantation, 15, 873–877.

    PubMed  Google Scholar 

  144. Taskinen, M., Saarinen Pihkala, U. M., Hovi, L., & Lipsanen-Nyman, M. (2000). Impaired glucose tolerance and dyslipidaemia as late effects after bone marrow transplantation in childhood. Lancet, 356, 993–997.

    PubMed  Google Scholar 

  145. Hoffmeister, P. A., Storer, B. E., & Sanders, J. E. (2004). Diabetes mellitus in long-term survivors of peiatric hematopietic cell transplantation. Journal of Pediatric Hematology/Oncology, 26, 81–90.

    PubMed  Google Scholar 

  146. d’Annunzio, G., Bonetti, F., Locatelli, F., Pistorio, A., & Lorini, R. (2005). Insulin resistance in children and adolescents after bone marrow transplant for haematological malignancies. Bone Marrow Transplantation, 35, 209–210.

    Google Scholar 

  147. Neville, K. A., Cohn, R. J., Steinbeck, K. S., Johnston, K., & Walker, J. L. (2006). Hyperinsulinemia, impaired glucose tolerance and diabetes mellitus in survivors of childhood cancer: Prevalence and risk factors. Journal of Clinical Endocrinology and Metabolism, 91, 4401–4407.

    PubMed  Google Scholar 

  148. Baker, K. S., Ness, K. K., Steinberger, J., Carter, A., Francisco, L., Burns, L. J., et al. (2007). Diabetes, hypertension and cardiovascular events in survivors of hematopoietic stem cell transplantation: A report from the bone marrow transplant survivor study. Blood, 109, 1765–1772.

    PubMed  Google Scholar 

  149. Chemaitilly, W., Boulad, F., Oeffinger, K. C., & Sklar, C. A. (2009). Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: A pilot study. Bone Marrow Transplantation, 44, 339–343.

    PubMed  Google Scholar 

  150. Tonorezos, E. S., Vega, L. G., Sklar, C. A., Chou, J. F., Moskowitz, C. S., Mo, Q., et al. (2010). Adipokines, body fatness and insulin resistance among survivors of childhood leukemia. Pediatric Blood & Cancer, 58(1), 31–36.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wassim Chemaitilly M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer New York

About this chapter

Cite this chapter

Chemaitilly, W. (2015). Endocrine System. In: Mucci, G., Torno, L. (eds) Handbook of Long Term Care of The Childhood Cancer Survivor. Specialty Topics in Pediatric Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7584-3_6

Download citation

Publish with us

Policies and ethics